BCWORLD PHARM. Co. Ltd (200780) — Cash Flow-to-Debt Ratio
BCWORLD PHARM. Co. Ltd (200780) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩1.43 Billion could theoretically repay 0% of its total liabilities (₩101.30 Billion) in one year. See financial agility of BCWORLD PHARM. Co. Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BCWORLD PHARM. Co. Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for BCWORLD PHARM. Co. Ltd across 10 annual periods. For the full cash flow conversion analysis, see 200780 cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year debt coverage analysis for BCWORLD PHARM. Co. Ltd. Check BCWORLD PHARM. Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | ₩4.04 Billion | ₩99.65 Billion | ▼ -62.0% |
| 2023 | 0.11x | ₩10.94 Billion | ₩102.47 Billion | ▲ +60.5% |
| 2022 | 0.07x | ₩6.88 Billion | ₩103.50 Billion | ▲ +1150.4% |
| 2021 | -0.01x | ₩-619.83 Million | ₩97.90 Billion | ▲ +89.5% |
| 2020 | -0.06x | ₩-5.50 Billion | ₩91.27 Billion | ▼ -137.6% |
| 2019 | 0.16x | ₩12.11 Billion | ₩75.53 Billion | ▲ +115.1% |
| 2018 | 0.07x | ₩5.34 Billion | ₩71.65 Billion | ▼ -65.0% |
| 2017 | 0.21x | ₩7.90 Billion | ₩37.11 Billion | ▲ +1869.4% |
| 2016 | 0.01x | ₩243.66 Million | ₩22.54 Billion | ▼ -98.5% |
| 2015 | 0.73x | ₩8.78 Billion | ₩11.96 Billion | — |